Autofluorescence has been a significant disadvantage when dealing with tomographic imaging of biological samples or tissue phantoms. Consequently, the accurate removal of autofluorescence signal has been a major concern in fluorescence tomography. Here we present a study on three-dimensional mapping and removal of autofluorescence from fluorescence molecular tomography (FMT) data, both for phantoms and small animal in vivo. The technique is based on the recording of tomographic data in multiple spectral regions with different excitation light and on the application of a linear unmixing algorithm for targeting multiple fluorescent probes. Two types of measurements are taken, one with the excitation being in the region of the maximum absorption of the targeted fluorophore and one in a region away from the maximum. The relative strengths of the different spectra are employed to calculate the signal to be removed from the tomographic reconstruction. Autofluorescence spectra are recorded using identical reflection geometry as during the FMT acquisitions allowing for the correct mapping of the autofluorescence signal. Results from phantoms exhibiting different background autofluorescence strengths are presented and discussed. In this work we have also studied in vivo fluorescent activity in mice, involving both subcutaneously implanted fluorescent phantoms and b10 transgenic mice.
INTRODUCTION
Optical imaging and tomography in tissues emerged as a valuable modality for the quantitative study of several important processes in biology and medicine 1, 2 . In recent years Fluorescence-mediated Molecular Tomography has been used in the study of several important functions and molecular pathways in-vivo in whole animals [3] [4] [5] . When applied in reflection geometry it can facilitate the detection of fluorescent signals from superficial organs and targets in a highly sensitive and quantitative fashion, by far improving imaging compared to the fluorescence photographic methods used to date 6 . However, skin autofluorescence, particularly when excited in the blue or green wavelengths, is a limiting factor for the contrast and sensitivity of the technique, significantly impairing imaging fidelity.
To overcome this drawback we have developed a technique for the complete mapping and removal of autofluorescence, which can be adaptively applied to any phantom or small animal in vivo experiment. The method is combined with a CCD-based Fluorescence Molecular Tomography (FMT) imager that has been designed and constructed for non-contact acquisitions of large data set and full 360° angle measurements of fluorescence activity. This imager has been used with transgenic mice for the investigation of various features of the immune system, particularly for studies of lymphocyte differentiation and tolerance. In these studies the emission from GFP expressing cells of b10 transgenic mice was detected to asses the system's ability in measuring fluorescence from cells in the lymphatic system. The methodology has also been applied to imaging the emission from other organs, such as the spleen and lymph nodes.
MATERIALS AND METHODS
The system that was used for the FMT acquisition as well as the autofluorescence FMT and spectral measurements is shown in Figure 1 . It consists of the FMT imager which employs an Argon ion cw multi-line laser (LaserPhysics, Reliant 1000m), a custom made imaging chamber, containing an x-y translation and a rotation stage (STANDA, Lithuania) and a 16bit, 1024x1024 pixels CCD camera (DV 434, ANDOR Belfast, Northern Ireland) thermoelectrically cooled down to -70°C, equipped with a 50mm Macro f/2.8 objective (SIGMA Corporation, Tokyo, Japan). The laser beam is coupled into a 600µm multimode fiber, and mounted on a 25 mm x-y translation stage. Then it is aligned to a beam collimator to receive a -1mm diameter-beam on the target. The excitation was performed at 488nm for the FMT data and at 457nm for the autofluorescence measurements. The latter excitation wavelength was chosen such that it lies bellow the absorption band of the targeted fluorophores. Different interference bandpass filters were used to record the fluorescence signal depending on the targeted fluorophore. For the acquisition of the autofluorescence spectra a spectrograph was used in combination with the CCD camera and the Argon ion laser, to cover a spectral range of about 200nm in the visible. The geometry was identical with the one used for the FMT acquisitions with the same number of illumination points. The contribution of the autofluorescence signal to the targeted fluorescence activity could then be calculated by integrating only that part of the recorded spectrum that corresponds to the filter bandpass.
The system allowed also for the accurate three dimensional reconstruction of the subject's surface using a back illumination setup and the appropriate algorithms 7 . The subject is back-illuminated with a homogeneous light source, projecting a shadow in the direction of the camera. The surface reconstruction is obtained by adding all projections (shadows) of the objects using an inverse Radon transform and keeping those voxels in space that are included in all projections 7, 8 . We were thus able to accurately render the fluorescence and autofluorescence signals on the reconstructed volume of the mice creating a map of the targeted organ fluorescence as well as the skin autofluorescence. 
Emission Filter
For the tomographic measurements, two kinds of measurements were taken, at different wavelength regions each time, with the same excitation wavelength. One measurement was taken by using a bandpass filter corresponding to the laser line used for excitation (457nm for autofluorescence and 488nm for fluorescence) and the second by using a bandpass filter corresponding to the fluorophore emission (540nm in the case of GFP). The reconstruction algorithm utilizes a normalized Born field that combines the acquired excitation and fluorescence measurements as follows:
where U fl (r s ,r d ) and U inc (r s ,r d ) are the photon fields measured at the emission and excitation wavelengths, respectively at location r d for a source at location r s . Θ f is a correction coefficient for the remnant transmittance of the excitation field trough the fluorescence filter. The recorded Born fields were inverted with an Algebraic Reconstruction Technique with positive restriction for the reconstruction of the 3D fluorescence concentration 9, 10 . The autofluorescence signal was reconstructed in a similar way. For the autofluorescence measurements we used a different excitation wavelength (457nm) but the emission was recorded at the same spectral region as previously (fluorophore emission). The spectral regions used during the acquisition of fluorescence and autofluorescence signals together with the filter bandpass profiles are shown in Figure 2 . In the same graph are depicted the absorption and emission spectra of GFP (green solid and dashed lines respectively) and the absorption spectrum of blood (black solid line) for better comparison. The procedure followed for the autofluorescence subtraction is to reconstruct the fluorescence and autofluorescence signals independently and then subtract the contribution of autofluorescence as shown in Equation 2. The multiplication factor is calculated from the relative integrated intensities of the autofluorescence signal over the two spectral regions of the filters in order to normalize for the difference in the recorded intensity. 
RESULTS AND DISCUSSION
To test the ability of our method to accurately remove autofluorescence we performed a study employing a cylindrical phantom made by adding 2% agar gel, 1% intralipid-20% (Pharmacia, Italy) and 0.02% India ink in distilled water, yielding approximate optical properties of µ s ′ = 15 cm -1 and µ a = 1.5 cm -1 . A capillary tube filled with CFSE (CarboxyFluorescein diacetate Succinimidyl Ester) is positioned approximately 4mm below the surface of the phantom. Intralipid is known to strongly fluoresce when excited with blue light. The measurements were performed following the procedure described above and the results are presented in Figure 3 where axial slices from the 3D reconstructed data are shown. Figure 3a shows reconstructed autofluorescence data which are localized on the surface only because CFSE fluorescence under 457nm excitation is very low. Figure 3b shows the corresponding data for fluorescence when excited at 488nm,where the tube as well as some autofluorescence is present and, finally, Figure 3c shows the real fluorescence signal from the tube after subtracting the autofluorescence signal from the Intralipid. The same procedure could be applied when imaging in vivo in mice by recording the skin autofluorescence at each illumination point used for the tomographic acquisitions. Autofluorescence signals originating from the skin of b10 mice (one GFP and one control) were recorded in vivo, using the experimental setup described above. The measurements were performed with the same geometry as during the FMT acquisitions, thus enabling the 3D reconstruction of the fluorescence distribution, as well as the 3D reconstruction of the surface of the mice. The spectra could then be accurately rendered on the skin surface for every illumination point as shown in Figure 5 . All measurements were performed in reflection mode which we have found more suitable for detecting signals originating from superficial organs being affected more by skin autofluorescence. The spectra were calculated from the mean values over nine sources at different positions (shown by the arrows and brackets) on the body. Note the differences in the corresponding spectra originating from the different emission depths of the GFP fluorescence, compared to the autofluorescence in the control mouse which is produced on the skin. The autofluorescence subtraction method described above was also tested in a biologically relevant study involving a GFP transgenic b10 mouse targeting the spleen. The results are presented in Figure 6 , where axial and coronal slices of the reconstructed data are plotted. Figures 3a and 3d show reconstructed autofluorescence data of the skin and the surrounding tissue. Figures 3b and 3e show the corresponding data for spleen fluorescence where some autofluorescence is also present and, finally, Figures 3c and 3f show the real fluorescence signal from the spleen after subtracting the autofluorescence signal of the skin and surrounding tissue. 
CONCLUSIONS
We have presented a method that was developed to overcome the limitations imposed to FMT by autofluorescence. It is based on the combined recording of FMT and autofluorescence data with different excitation light and the acquisition of autofluorescence spectra at an identical geometry to the FMT. Hence, a 3D mapping of autofluorescence can be obtained and accurate subtraction from fluorescence activity signals can be performed. Furthermore the tomographic system can facilitate the detection of fluorescence in many spectral regions using different filters and applying simple spectral deconvolution algorithms for distinguishing different fluorophores with overlapping spectral signatures. The same algorithm can furthermore be applied to tissue-specific spectroscopy data. Spectral analysis of a variety of organs from control, DsRed and GFP F5/B10 transgenic mice showed that fluorophore detection by optical systems is highly tissuedependent. Spectral data collected from different organs can provide useful insight into experimental parameter optimization (choice of filters, fluorophores and excitation wavelengths) and spectral unmixing can be applied to measure the tissue-dependency, thereby taking into account localized fluorophore efficiency. Furthermore, this tissue specific spectral information can then be implemented in the building of the weight matrix providing a spectral constraint in the inversion algorithm resulting in a more robust reconstruction 11, 12 . The spectral information needed for the implementation of the relative strengths of different spectral contributions in the wavelength dependent weight matrix can be obtained by spectrally-resolved tomographic measurements of the fluorophore emission initially in phantoms and then inside the animals. In conclusion, highly contrast tomographic images can be obtained and better quantification accuracy can be achieved, improving our ability for in vivo detection and monitoring of fluorescent signals in whole animals.
